openPR Logo
Press release

Transdermal Scopolamine Market : Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2024

01-24-2020 01:57 PM CET | Health & Medicine

Press release from: TMR

TMR observes that the global transdermal scopolamine market is experiencing the high competition and consolidation due to presence of strong players. Some of the key players operating in the global transdermal scopolamine market includes Baxter International Inc., Novartis AG, GlaxoSmithKline Plc, Caleb Pharmaceuticals Inc, Perrigo Co. Plc, and Myungmoon Pharma Co. Ltd. Among them, Novartis AG accounted for nearly 41.0% of the overall revenue in 2016 of the global transdermal scopolamine market. GlaxoSmithKline Plc and Baxter International Inc., accounted for 49.0% of shares together in the same year. The presence of small companies in the market are intensifying competition and international players are adopting the strategies like acquiring small or local companies to strengthen their presence in region and for business expansion.

transdermal scopolamine market

The global revenue of the market was registered at a value of US$330.0 mn in 2015, is projected to grow at a CAGR of 6.70% over the forecast period from 2016 to 2024 to attain the value of a US$585.3 mn by the end of 2024. Regionally, the market is dominated by North America being the well-established market for players operating in healthcare industry coupled with high expenditure capacity of people on healthcare, and penetration of transdermal scopolamine in surgeries and post-operative recovery.

Growing Adoption to Withdraw Postsurgical Effects to Drive Growth


Increasing awareness about the effectiveness of transdermal scopolamine in the treatment of motion sickness is boosting adoption of transdermal scopolamine. This factor is likely to boost the growth of the global transdermal scopolamine market. Additionally, growing number of travels and travelers using the transdermal scopolamine as safety purposes is bolstering growth of the global transdermal scopolamine market.

For More Details, Request A PDF Brochure Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22322

In addition, transdermal scopolamine are helpful in the control on hyper salivation and possess the properties of faster recovery from anesthesia, postoperative vomiting, and nausea. Owing to these advantages, the transdermal scopolamine are increasingly used in the surgeries mainly for controlling salivation and withdrawing its side effects are fueling demand for growth of the global transdermal scopolamine market. Thanks of these factors the market is witnessing substantial growth.

Possible Side Effects of Patches to Hamper Growth

Despite of this growth, the possible side-effects caused by the consumption of the products such as drowsiness, retarded motion, and diluted pupils are hampering growth of the global transdermal scopolamine market. Additionally, presence of stringent regulations related to manufacturing and selling these products are crimping growth of the global transdermal scopolamine market.

Nevertheless, rising awareness in the developing countries are boosting demand and expected to offer lucrative growth opportunities. The higher production from the small and mid-scale companies operating in developing regions is creating growth of the global transdermal scopolamine market. In addition, improving healthcare sector globally and booming medical tourism are offering the immense potential to these companies for growth.


This information is comprised in the new report by TMR, titled "Transdermal Scopolamine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."

The global transdermal scopolamine market has been segmented as presented:

By Geography

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal Scopolamine Market : Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2024 here

News-ID: 1907977 • Views: 152

More Releases from TMR

02-11-2020 | Health & Medicine
TMR
Bone Growth Stimulators Market Is Likely To Tread Along A Healthy Growth Track O …
Bone Growth Stimulators Market: Introduction According to the report, the global bone growth stimulators market was valued at US$ 1.3 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027. Bone growth stimulation is a therapy used to aid bone healing process after a fracture or spinal fusion surgery. Rise in geriatric population globally, increase in prevalence of orthopedic diseases and rising inclination of
02-11-2020 | Health & Medicine
TMR
HIV Self-test Kits Market Report Examines Growth Overview And Predictions On Siz …
HIV Self-test Kits Market: Introduction According to the report, the global HIV self-test kits market was valued at US$ 60.3 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. HIV self-testing is a screening test, which detects the presence of HIV-1/2 antibodies. HIV self-testing is a test in which a person collects his/her own specimen and performs an HIV test in a private
02-11-2020 | Health & Medicine
TMR
Fetal Monitoring Systems Market Size Examines Growth Overview And Predictions On …
Fetal Monitoring Systems Market: Introduction Transparency Market Research has published a new report titled "Fetal Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027". According to the report, the global fetal monitoring systems market was valued at approximately US$ 2.8 Bn in 2018. It is expected to expand at a CAGR of ~3% during the forecast period from 2019 to 2027. Monitoring procedures are the basis
02-11-2020 | Health & Medicine
TMR
Orthopedic Biomaterials Market Size Is In Tremendous Growth Phase | Analysis Rep …
Orthopedic Biomaterials Market: Introduction According to the report, the global orthopedic biomaterials market was valued at US$ 11.3 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Rise in percentage of population requiring orthopedic implants, and increase in incidence rate of injuries related to accidents, sports, and adventure are anticipated to augment the global orthopedic biomaterials market from 2019 to 2027. North America

All 5 Releases


More Releases for Plc

Statins Market Key Players : AstraZeneca plc, Pfizer Inc., GlaxoSmithKline plc
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. Demand for statins is long driven by increasing healthcare awareness among common masses. In U.S., over 500,000 people suffers heart attack every year. Though cholesterol level is easy to
Programmable Logic Controller (PLC) Market -
Programmable Logic Controller (PLC) technology is not recent in the industry, and is still in usage at a great extent by manufacturing companies. Programmable Logic Controller smoothens the mechanical automation process in manufacturing units and construction buildings. Due to its dynamic development, sequential control, counters and timers, ease of programming, reliable controlling capabilities, and ease of hardware usage; Programmable Logic Controllers are also utilized in various control system areas. Browse The
Online Gambling Global Market 2018: Key Players – William Hill Plc., Paddy Pow …
Online Gambling Industry Description Wiseguyreports.Com Adds “Online Gambling -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database Online Gambling refers to betting of money online on an event with an uncertain outcome. Online gambling is similar to gambling but the difference is that online gambling is betting on sports or casino over the internet. Online gambling is not limited to playing cards. It is a
Antibacterial Drugs Market: Allergen plc, AstraZeneca plc, Bayer AG
New York, February 14: Market Research Engine has published a new report titled as “Antibacterial Drugs Market By Class (Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Macrolides, Phenicols and Pipeline Drugs) - Global Industry Analysis, Trends and Forecast 2015 - 2023” The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2023 growing at a CAGR of 1.30% during the given forecast period. Browse Full Report: https://www.marketresearchengine.com/reportdetails/antibacterial-drugs-market The term Antibiotic refers to antimicrobials which are
FATEK PLC
* FATEK FBs Series PLC- The FBs-PLC has more than 300 instructions which adopts a user friendly and readable multi-input/multi-output function structure. With this multi-input instruction structure the user can derive many types of functionality which other brands of PLC’s may require the use of many instructions to achieve this. * FATEK B1/B1z Series PLC- Economical and High-Quality PLC FATEK B1/B1z Series Micro-Programmable Controllers The streamline design of SoC technology significantly reduces the hardware costs.
SANYO PLC-XP200L & PLC-XC55 Multimedia Projectors
San Diego, CA, December 5, 2008 Audio Video Supply, Inc, a San Diego distributor first in presentation technology, has introduced the new Sanyo PLC-XP200L XGA Multimedia Projector and Sanyo PLC-XC55 Portable Multimedia LCD Projector from its new product line. The Sanyo PLC-XP200L is the world’s first 4LCD optical engine, making it the brightest projector in its class. The PLC-XP200L packs 7,000 lumens produced from a 330-watt lamp. The new QuaDrive